FDA-filed SPL labeling · retrieved through openFDA

Fluticasone / Salmeterol

Fluticasone/salmeterol is a two-in-one inhaler that helps control asthma and COPD by reducing airway inflammation and keeping the airways open.

Brand names Advair HfaFluticasone Propionate and Salmeterol DISKUSAdvair DiskusAdvairWixela Inhub +3 more
Drug classes Corticosteroid
Rx Forms 2 Route Respiratory (inhalation)
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 34 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveAug 8, 2025
Clinical labels in scope 34
AvailabilityRx
Earliest approval/marketing year 2001
FDA-listed product records 120
Boxed warningNone found in compared labels
How we combine label and product data →
No current FDA shortage listed · checked Sep 22, 2026
Fluticasone / Salmeterol at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Fluticasone/salmeterol is a powerful twice-daily maintenance inhaler that combines an anti-inflammatory steroid with a long-acting airway opener — it's designed for daily control of asthma or COPD, not for sudden flares. Always keep a fast-acting rescue inhaler nearby, rinse your mouth after every use, and never add another long-acting beta-agonist. Regular follow-ups with your doctor help catch any long-term side effects early.

📖 Fluticasone / Salmeterol: Patient Information Guide

A plain-language walkthrough of Fluticasone / Salmeterol — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for

Fluticasone/salmeterol treats chronic breathing conditions that need ongoing, daily management:

  • Asthma — twice-daily control in patients aged 4 and older who are not adequately managed on an inhaled steroid alone
  • COPD (chronic obstructive pulmonary disease) — including chronic bronchitis and emphysema, for maintenance treatment and to reduce flare-ups

Not for emergencies: This inhaler does not work fast enough to treat a sudden asthma attack or COPD flare — always have a short-acting rescue inhaler available.

⚙️How it works

Fluticasone is a synthetic corticosteroid (anti-inflammatory medicine) that acts directly in the lungs. It works on many cell types — including mast cells, eosinophils, and macrophages — to quiet the inflammation that underlies both asthma and COPD. Salmeterol is a selective long-acting beta-agonist (LABA): it binds tightly to receptors on the muscles surrounding the airways, causing those muscles to relax and the airways to stay open for about 12 hours per dose.

Because inflammation and airway tightening both drive breathing problems, combining these two medicines in one inhaler addresses the condition from two angles at once.

💊How it's taken

Fluticasone/salmeterol is inhaled through the mouth — one inhalation twice daily, taken roughly 12 hours apart. It is a dry powder inhaler; food does not affect how it works. After each inhalation, rinse your mouth with water and spit — do not swallow the water — to reduce the chance of a mouth yeast infection.

  • Do not take more than one inhalation per dose
  • Do not use a second long-acting beta-agonist (LABA) alongside this inhaler
  • If asthma symptoms flare between doses, use your short-acting rescue inhaler
  • If you miss a dose, take it as soon as you remember — but if it is almost time for your next dose, skip the missed one and continue your regular schedule
🤒Side effects — in detail

Most side effects from this inhaler are manageable, but it is worth knowing what to watch for:

  • Upper respiratory infections or nasal/throat inflammation
  • Sore throat (pharyngitis)
  • Hoarse or changed voice (dysphonia)
  • Oral thrush — yeast infection of the mouth (oral candidiasis); rinsing after each use reduces this risk
  • Bronchitis or cough
  • Headache
  • Nausea or vomiting
  • Musculoskeletal (muscle and bone) pain — more common in COPD patients
  • Pneumonia — a particular concern in people with COPD

Contact your doctor promptly if you experience chest pain, rapid or irregular heartbeat, sudden worsening of breathing, white patches in your mouth, vision changes, or signs of infection.

⚠️Warnings & precautions
  • LABA safety: Using salmeterol without an inhaled corticosteroid raises the risk of serious asthma events including death — this combination keeps them together for safety. Never add another LABA.
  • Not a rescue inhaler: Do not use this for sudden symptoms — it will not act fast enough. Use a short-acting bronchodilator (like albuterol) for emergencies.
  • Increased infection risk: Inhaled corticosteroids can weaken local immune defenses; existing infections (tuberculosis, fungal, viral, herpes) may worsen. Chickenpox and measles can be more severe.
  • Adrenal suppression: Switching from oral steroids to this inhaler must be done gradually — stopping oral steroids too quickly can leave your body without enough cortisol.
  • Bone density: Long-term use can reduce bone mineral density; your doctor may monitor this periodically.
  • Children's growth: Inhaled corticosteroids may slow growth in children — regular monitoring is important.
  • Eye health: Long-term use raises the risk of glaucoma (increased eye pressure) and cataracts. Report any vision changes.
  • Heart and nervous system: Salmeterol can affect heart rate and rhythm — use with caution if you have cardiovascular disease or a seizure disorder.
🔀What it interacts with

Several medicines can interact meaningfully with fluticasone/salmeterol — tell your pharmacist and doctor about everything you take:

  • Strong CYP3A4 inhibitors (ritonavir, ketoconazole, clarithromycin, itraconazole, and others): significantly raise fluticasone levels in the blood, increasing the risk of adrenal suppression and other steroid side effects — avoid this combination.
  • MAO inhibitors and tricyclic antidepressants: can amplify salmeterol's effect on the cardiovascular system — use with extreme caution.
  • Beta-blockers (atenolol, metoprolol, propranolol, etc.): may block salmeterol's bronchodilator (airway-opening) effect and potentially cause severe bronchospasm.
  • Non-potassium-sparing diuretics (certain water pills like furosemide): can worsen low potassium levels and heart rhythm changes when combined with salmeterol.
  • Other LABAs: Do not use any other long-acting beta-agonist — the overlapping effect raises overdose risk.

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it
  • Do not use if you are allergic to fluticasone, salmeterol, or milk proteins (the inhaler contains milk-derived lactose).
  • Do not use as the primary treatment for a severe, acute asthma or COPD attack requiring emergency care.
  • Tell your doctor if you have heart disease, high blood pressure, or heart rhythm problems.
  • Tell your doctor about any history of seizures, thyroid disease, diabetes, or glaucoma/cataracts.
  • If you are pregnant: poorly controlled asthma poses risks to mother and baby — your doctor will help weigh the benefits and risks of continuing this medicine.
  • If switching from oral corticosteroid pills: do not stop them abruptly; your doctor must taper the dose slowly.
  • Liver disease: drug levels may be higher — your doctor should monitor you more closely.
  • Children (aged 4–11): approved for asthma use, but growth should be monitored regularly.
🚑If you take too much

Too much salmeterol can cause excessive stimulation of the heart and nervous system — signs include rapid heart rate, chest pain (angina), tremor, headache, muscle cramps, nausea, dizziness, low potassium, high blood sugar, and in severe cases, dangerous heart rhythm problems or cardiac arrest. Too much fluticasone over time can lead to signs of excess steroid in the body (hypercorticism), such as weight gain, easy bruising, or adrenal gland problems.

If you suspect an overdose, stop the inhaler and seek medical care immediately — heart monitoring is recommended, and a doctor will provide appropriate treatment.

📡Pharmacodynamics — effects in the body

At normal therapeutic doses, salmeterol's effects on the heart are not typically noticeable, but at higher doses it can affect pulse rate, blood pressure, heart rhythm (QTc interval), potassium levels, and blood sugar. Studies in healthy volunteers showed that these cardiovascular and metabolic effects were the same whether salmeterol was given alone or as part of this combination inhaler — meaning fluticasone doesn't change how salmeterol acts on the body, and vice versa. The presence of fluticasone also did not significantly alter the body's natural cortisol (adrenal) response in healthy subjects.

🔬Pharmacokinetics — how your body processes it

Fluticasone acts mainly in the lungs — very little (less than 1%) is absorbed into the bloodstream from swallowing, but a meaningful amount of what reaches the lungs is absorbed systemically. Peak blood levels appear within 1 to 2 hours of inhalation. Salmeterol is also absorbed through the lungs. Both medicines are broken down by a liver enzyme system called CYP3A4, which is why strong inhibitors of that enzyme can raise drug levels significantly and cause extra side effects. Rinsing the mouth after use prevents swallowed drug from being absorbed through the gut.

📦How to store it

Store at room temperature between 68°F and 77°F (20°C and 25°C); excursions permitted from 59°F to 86°F (15°C to 30°C) . Store in a dry place away from direct heat or sunlight. Keep out of reach of children.

📄 Written from Fluticasone / Salmeterol’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Fluticasone / Salmeterol — the kind of thing our pharmacy team would talk through with you at the counter.

Can I use this inhaler when I'm having an asthma attack right now?
No — and this is really important. Fluticasone/salmeterol is a maintenance inhaler designed to prevent breathing problems over time, not to act fast in an emergency. It won't open your airways quickly enough to help during an acute attack. Always keep a short-acting rescue inhaler, like albuterol, nearby for sudden flares. If your rescue inhaler isn't helping, call 911.
Why do I have to rinse my mouth after using this inhaler?
The inhaled steroid (fluticasone) can leave a tiny bit of medicine in your mouth and throat. That residue can allow a yeast called Candida to grow, causing oral thrush — white patches and soreness in your mouth. Rinsing with water and spitting it out washes that residue away. It's one of the simplest things you can do to avoid a common side effect, so make it a habit every single time you use the inhaler.
I take ritonavir for HIV — is it safe to use this inhaler?
This is a combination your doctor really needs to know about. Ritonavir blocks the enzyme that breaks down fluticasone, so fluticasone can build up to much higher levels than intended in your body. That can suppress your adrenal glands and cause serious hormonal side effects. The label specifically says this combination is not recommended. Bring it up with your HIV specialist and the prescriber of this inhaler so they can find a safe plan together.
I've been on oral steroid pills for years. Can I just switch to this inhaler and stop the pills?
You should never stop oral steroids suddenly — your body may have become reliant on them to produce a hormone called cortisol, and stopping abruptly can leave you without enough of it, which can be serious. Your doctor will create a gradual tapering schedule to slowly reduce the pills while you start this inhaler. During the changeover, watch for signs like unusual fatigue, weakness, or nausea, and tell your doctor right away if those appear.
My child is 6 years old — is this inhaler safe for kids?
Yes, fluticasone/salmeterol is approved for asthma in children aged 4 and older. That said, inhaled steroids can sometimes slow growth slightly in children, so your doctor will monitor your child's height at regular visits. It's not a reason to avoid the medicine when it's needed — uncontrolled asthma is the bigger risk — but it's something the pediatrician will keep an eye on over time.
I'm pregnant — should I keep using this inhaler?
Staying in touch with your doctor is the most important step here. Poorly controlled asthma during pregnancy carries real risks for both you and your baby, including preterm birth and low birth weight. The goal is to keep your asthma well managed throughout pregnancy, and your doctor will help weigh the benefits of continuing the inhaler against any potential risks. Don't stop using it without talking to your provider first.
Is Fluticasone / Salmeterol available over the counter?
Fluticasone / Salmeterol is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
When was Fluticasone / Salmeterol first available?
Fluticasone / Salmeterol has been available in the United States since at least 2001, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Fluticasone / Salmeterol?
Fluticasone / Salmeterol is supplied by 14 manufacturers listed in the FDA NDC Directory, including A-S Medication Solutions, GlaxoSmithKline LLC, Prasco Laboratories.

💬 Answers drafted from Fluticasone / Salmeterol’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Fluticasone / Salmeterol comes

Fluticasone / Salmeterol is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

📊 Fluticasone / Salmeterol across the U.S. market

How Fluticasone / Salmeterol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

2
Dose forms
14
Manufacturers
9
Brand names
120
FDA-listed product records
2001
First marketed

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

A-S Medication Solutions22%
GlaxoSmithKline LLC15%
Prasco Laboratories13%
Teva Respiratory, LLC10%
Bryant Ranch Prepack8%
Teva Pharmaceuticals USA, Inc.8%
Other makers25%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Fluticasone / Salmeterol is used

A general measure of how commonly Fluticasone / Salmeterol is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Fluticasone / Salmeterol is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

1,781,081
Medicaid prescriptions filled (Q1–Q4 2025)
$405.3M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Fluticasone / Salmeterol prescribed? Of the 1,596 medications we measure, Fluticasone / Salmeterol ranks #120 by Medicaid prescriptions — more than 92% of them.

Where Fluticasone / Salmeterol ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Fluticasone / Salmeterol product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 60 actuation / 0.25 mg/actuation / 0.05 mg/actuation dry powder inhaler is the most-dispensed Fluticasone / Salmeterol product — about 41% of these Medicaid prescriptions.

60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler Most dispensed

731,212 Medicaid prescriptions (Q1–Q4 2025) 41% of Fluticasone / Salmeterol prescriptions shown $132.3M gross reimbursement (before rebates) ≈ $181 per prescription (gross)

Summed across the 5 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896209

60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler

272,642 Medicaid prescriptions (Q1–Q4 2025) 15% of Fluticasone / Salmeterol prescriptions shown $39M gross reimbursement (before rebates) ≈ $143 per prescription (gross)

Summed across the 5 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896184

60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler

261,392 Medicaid prescriptions (Q1–Q4 2025) 15% of Fluticasone / Salmeterol prescriptions shown $66.1M gross reimbursement (before rebates) ≈ $253 per prescription (gross)

Summed across the 5 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896228

120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler

223,702 Medicaid prescriptions (Q1–Q4 2025) 13% of Fluticasone / Salmeterol prescriptions shown $74.1M gross reimbursement (before rebates) ≈ $331 per prescription (gross)

Summed across the 2 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896244

120 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler

135,817 Medicaid prescriptions (Q1–Q4 2025) 8% of Fluticasone / Salmeterol prescriptions shown $64M gross reimbursement (before rebates) ≈ $471 per prescription (gross)

Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896272

120 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler

77,980 Medicaid prescriptions (Q1–Q4 2025) 4% of Fluticasone / Salmeterol prescriptions shown $20.2M gross reimbursement (before rebates) ≈ $259 per prescription (gross)

Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896236

60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler

38,959 Medicaid prescriptions (Q1–Q4 2025) 2% of Fluticasone / Salmeterol prescriptions shown $4.7M gross reimbursement (before rebates) ≈ $119 per prescription (gross)

Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1918203

60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler

33,451 Medicaid prescriptions (Q1–Q4 2025) 2% of Fluticasone / Salmeterol prescriptions shown $4M gross reimbursement (before rebates) ≈ $121 per prescription (gross)

Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1918194

60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler

5,264 Medicaid prescriptions (Q1–Q4 2025) <1% of Fluticasone / Salmeterol prescriptions shown $680,919 gross reimbursement (before rebates) ≈ $129 per prescription (gross)

Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1918209

60 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler

415 Medicaid prescriptions (Q1–Q4 2025) <1% of Fluticasone / Salmeterol prescriptions shown $47,977 gross reimbursement (before rebates) ≈ $116 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896239

60 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler

236 Medicaid prescriptions (Q1–Q4 2025) <1% of Fluticasone / Salmeterol prescriptions shown $51,878 gross reimbursement (before rebates) ≈ $220 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896267

60 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler

11 Medicaid prescriptions (Q1–Q4 2025) <1% of Fluticasone / Salmeterol prescriptions shown $1,769 gross reimbursement (before rebates) ≈ $161 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896231

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Fluticasone / Salmeterol, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 30 of 66 listed Fluticasone / Salmeterol NDCs with Medicaid activity.

🔍 Compare Fluticasone / Salmeterol products

A representative set of FDA-listed product records for Fluticasone / Salmeterol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 120 of 120 products — FDA National Drug Code Directory. See every product, package size and price: browse all 120 Fluticasone / Salmeterol NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.

Multiple ingredients (MIN) Fluticasone / Salmeterol RxCUI 284635 2 dose forms · 18 strengths
  1. Dose form (SCDF) Dry Powder Inhaler RxCUI 746717 In current FDA listings
    Clinical drug / strength (SCD) Sensor 60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT RxCUI 2395829 Sensor 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT RxCUI 2395826 Sensor 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT RxCUI 2395832 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT RxCUI 896161 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT RxCUI 896186 14 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT RxCUI 896218 60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT RxCUI 1918209 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT RxCUI 896184 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT RxCUI 1918194 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT RxCUI 1918203 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT RxCUI 896209 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT RxCUI 896228
  2. Dose form (SCDF) Metered Dose Inhaler RxCUI 744485 In current FDA listings

Look up RxCUI 284635 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Advair Hfa Fluticasone Propionate and Salmeterol DISKUS Advair Diskus Advair Wixela Inhub AirDuo Digihaler AirDuo RespiClick Fluticasone Propionate and Salmeterol HFA

🏭 Manufacturers & labelers

A-S Medication Solutions 26 GlaxoSmithKline LLC 18 Prasco Laboratories 15 Teva Respiratory, LLC 12 Bryant Ranch Prepack 10 Teva Pharmaceuticals USA, Inc. 9 Remedyrepack Inc. 9 Hikma Pharmaceuticals USA Inc. 8 Mylan Pharmaceuticals Inc. 3 Preferred Pharmaceuticals Inc. 3 Cipla USA Inc. 3 Lannett Company, Inc. 2 Proficient Rx LP 1 RPK Pharmaceuticals, Inc. 1

RxNorm drug class

Fluticasone / Salmeterol belongs to the beta2-Adrenergic Agonist class.

Pharmacologic class beta2-Adrenergic Agonist
Drug family (ATC) Selective beta-2-adrenoreceptor agonists
How it works Adrenergic beta2-Agonists

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Aug 8, 2025
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Fluticasone / Salmeterol.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Fluticasone / Salmeterol after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
34
NDC products indexed
120
Distinct labelers/manufacturers represented
14
Linked representative label
A-S Medication Solutions
Linked label effective
Aug 8, 2025
Composite sections available
23
Linked SPL Set ID
80b36523-4ae4-463e-b1fd-b929fb802b76
Linked SPL Document ID
60f8570f-0853-4add-ae12-6cb19839089d
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 34 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. A-S Medication Solutions is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.